Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Reactive Focal Mass Drug Administration (rfMDA) in Namibia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02610400
Recruitment Status : Completed
First Posted : November 20, 2015
Last Update Posted : January 4, 2019
Sponsor:
Collaborators:
University of Texas
London School of Hygiene and Tropical Medicine
University of Southampton
The Novartis Foundation
Clinton Health Access Initiative, Nigeria
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):